Ferroptosis: a critical mechanism of N6-methyladenosine modification involved in carcinogenesis and tumor progression

被引:0
|
作者
Qingqing Wei [1 ,2 ,3 ]
Changning Xue [1 ,2 ,3 ]
Mengna Li [1 ,2 ,3 ]
Jianxia Wei [1 ,2 ,3 ]
Lemei Zheng [1 ,2 ,3 ,4 ]
Shipeng Chen [1 ,2 ,3 ]
Yumei Duan [1 ,2 ,3 ]
Hongyu Deng [1 ,2 ,4 ]
Faqing Tang [1 ,2 ,4 ]
Wei Xiong [1 ,2 ,3 ]
Ming Zhou [1 ,2 ,3 ,4 ]
机构
[1] NHC Key Laboratory of Carcinogenesis, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University
[2] Cancer Research Institute and School of Basic Medical Sciences, Central South University
[3] The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Central South University
[4] Hunan Key Laboratory of Oncotarget Gene, Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University
基金
中国国家自然科学基金;
关键词
D O I
暂无
中图分类号
R730 [一般性问题];
学科分类号
100214 ;
摘要
Ferroptosis is an iron-dependent regulatory cell necrosis induced by iron overload and lipid peroxidation. It occurs when multiple redoxactive enzymes are ectopically expressed or show abnormal function. Hence, the precise regulation of ferroptosis-related molecules is mediated across multiple levels, including transcriptional, posttranscriptional, translational, and epigenetic levels. N6-methyladenosine(m6A) is a highly evolutionarily conserved epigenetic modification in mammals. The m6A modification is commonly linked to tumor proliferation, progression, and therapy resistance because it is involved in RNA metabolic processes. Intriguingly, accumulating evidence suggests that dysregulated ferroptosis caused by the m6A modification drives tumor development. In this review, we summarized the roles of m6A regulators in ferroptosis-mediated malignant tumor progression and outlined the m6A regulatory mechanism involved in ferroptosis pathways. We also analyzed the potential value and application strategies of targeting m6A/ferroptosis pathway in the clinical diagnosis and therapy of tumors.
引用
收藏
页码:1119 / 1132
页数:14
相关论文
共 50 条
  • [21] Autophagy activation is required for N6-methyladenosine modification to regulate ferroptosis in hepatocellular carcinoma
    Li, Yujia
    Guo, Mei
    Qiu, Yangling
    Li, Mengran
    Wu, Yang
    Shen, Min
    Wang, Yingqian
    Zhang, Feng
    Shao, Jiangjuan
    Xu, Xuefen
    Zhang, Zili
    Zheng, Shizhong
    REDOX BIOLOGY, 2024, 69
  • [22] N6-methyladenosine modification: an important player in the tumor immune microenvironment
    Hu, Jiaxiang
    Xue, Chen
    Wang, Qingqing
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 165
  • [23] Epitranscriptic regulation of HRAS by N6-methyladenosine drives tumor progression
    Pan, Yongbo
    Gu, Yinmin
    Liu, Tihui
    Zhang, Qingqing
    Yang, Facai
    Duan, Liqiang
    Cheng, Shuwen
    Zhu, Xiaofeng
    Xi, Yibo
    Chang, Xiaoli
    Ye, Qinong
    Gao, Shan
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120 (14)
  • [24] The dual role of N6-methyladenosine modification of RNAs is involved in human cancers
    He, Liujia
    Li, Jiangfeng
    Wang, Xiao
    Ying, Yufan
    Xie, Haiyun
    Yan, Huaqing
    Zheng, Xiangyi
    Xie, Liping
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2018, 22 (10) : 4630 - 4639
  • [25] Mechanism of N6-methyladenosine modification and its emerging role in cancer
    Zhang, Sicong
    PHARMACOLOGY & THERAPEUTICS, 2018, 189 : 173 - 183
  • [26] Function of N6-Methyladenosine Modification in Tumors
    Zhang, Nan
    Zuo, Yuxin
    Peng, Yu
    Zuo, Lielian
    JOURNAL OF ONCOLOGY, 2021, 2021
  • [27] Publisher Correction: Functions of RNA N6-methyladenosine modification in cancer progression
    Bing Chen
    Ya Li
    Ruifeng Song
    Chen Xue
    Feng Xu
    Molecular Biology Reports, 2023, 50 : 7953 - 7953
  • [28] The N6-methyladenosine modification in pathologic angiogenesis
    Li, Bin
    Xuan, Hanqin
    Yin, Yuye
    Wu, Shusheng
    Du, Longfei
    LIFE SCIENCES, 2024, 339
  • [29] The functions of N6-methyladenosine modification in lncRNAs
    He, Rong-Zhang
    Jiang, Jing
    Luo, Di-Xian
    GENES & DISEASES, 2020, 7 (04) : 598 - 605
  • [30] Role of N6-methyladenosine modification in cancer
    Deng, Xiaolan
    Su, Rui
    Feng, Xuesong
    Wei, Minjie
    Chen, Jianjun
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 2018, 48 : 1 - 7